Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -184,400
▼ 98% vs 2024
Profit
Caution€ -219,285
▼ 71% vs 2024
Debts
Low€ 536,297
▲ 13% vs 2024
Center for Beta Cell Therapy in Diabetes from Jette, company number BE0872566468, closed financial year 2025 with a result of € -219,285 after tax. For that financial year Center for Beta Cell Therapy in Diabetes recorded a gross margin of € -184,400 and equity of € 2.6 million. Compared with financial year 2024, the result moved from € -128,261 to € -219,285. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
What happened at Center for Beta Cell Therapy in Diabetes?
What happened at Center for Beta Cell Therapy in Diabetes in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 219,285. Source: NBB ↗
- New establishment in Jette. KBO
- Start of the company according to the CBE. KBO
In short
From € 228,055 profit in 2021 to € 219,285 loss in 2025.
Best year ever: 2021, with € 228,055 profit.
A new publication or filing at Center for Beta Cell Therapy in Diabetes? We notify you, reason included.
Follow Center for Beta Cell Therapy in DiabetesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Center for Beta Cell Therapy in Diabetes are Bart Keymeulen, Daniël Pipeleers and Sabrina Uyttenhove. The same people are also behind OPUS, BETA - CELL and Drs Pipeleers & Marichal.
Directors
According to the 2025 annual accounts
Bart Keymeulen
Director
Establishments
Establishment units
Physical locations of this company
Laarbeeklaan 103
1090 Jette
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Details
- Company number
- 0872.566.468
- VAT number
- BE 0872.566.468
- Registered office
- Laarbeeklaan 103, 1090 Jette
- Names & denominations
- Center for Beta Cell Therapy in Diabetes
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 17 March 2005
- Peppol
- Active · Active since 17 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied